Cargando…

TDO Promotes Hepatocellular Carcinoma Progression

PURPOSE: Tryptophan 2,3-dioxygenase (TDO), encoded by the gene TDO2, is an enzyme that catalyses the first and rate-limiting step of tryptophan (Try) degradation in the kynurenine (Kyn) pathway in the liver. Recently, TDO has been demonstrated to be expressed in various human tumours, especially hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shanbao, Li, Lei, Wu, Junyi, Song, Fangbin, Qin, Zhiwei, Hou, Lei, Xiao, Chao, Weng, Junyong, Qin, Xuebin, Xu, Junming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311207/ https://www.ncbi.nlm.nih.gov/pubmed/32606795 http://dx.doi.org/10.2147/OTT.S252929

Ejemplares similares

Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression
por: Li, Shanbao, et al.
Publicado: (2020)

TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
por: Li, Lei, et al.
Publicado: (2021)

Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
por: Li, Shanbao, et al.
Publicado: (2023)

Elevated HOXA13 expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2
por: Qin, Zhiwei, et al.
Publicado: (2019)

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy
por: Song, Fangbin, et al.
Publicado: (2017)

Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantation
por: Cao, Wanyue, et al.
Publicado: (2022)

MiR-126-5p Promotes Tumor Cell Proliferation, Metastasis and Invasion by Targeting TDO2 in Hepatocellular Carcinoma
por: Ai, Yang, et al.
Publicado: (2022)

TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27
por: Yu, Chengpeng, et al.
Publicado: (2021)

TDO2(+) myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma
por: Hu, Simeng, et al.
Publicado: (2022)

Clinicopathologic features of TDO2 overexpression in renal cell carcinoma
por: Pham, Quoc Thang, et al.
Publicado: (2021)

Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway
por: Wu, Zhengzhong, et al.
Publicado: (2021)

Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination
por: Li, Tianyi, et al.
Publicado: (2018)

Cancer Associated Fibroblasts Promote Renal Cancer Progression Through a TDO/Kyn/AhR Dependent Signaling Pathway
por: Chen, Li-bo, et al.
Publicado: (2021)

On the Non-Redundant Roles of TDO2 and IDO1
por: Puccetti, Paolo
Publicado: (2014)

Pharmacological validation of TDO as a target for Parkinson’s disease
por: Perez‐Pardo, Paula, et al.
Publicado: (2021)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer
por: Weng, Junyong, et al.
Publicado: (2018)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

Identification and optimisation of next generation inhibitors of IDO1 and TDO
por: Wise, Alan, et al.
Publicado: (2015)

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2020)

Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
por: Ye, Zixiang, et al.
Publicado: (2019)

Wideband TDoA Positioning Exploiting RSS-Based Clustering
por: Fuchs, Andreas, et al.
Publicado: (2023)

hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR‐139‐3p/CCL5 axis
por: Cao, Pei, et al.
Publicado: (2021)

RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition
por: Zhang, Yang, et al.
Publicado: (2021)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Design and Implementation of Real-Time Localization System (RTLS) Based on UWB and TDoA Algorithm
por: Zhang, Fengyun, et al.
Publicado: (2022)

NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway
por: Zhao, Jing, et al.
Publicado: (2017)

Extracellular Vesicles Secreted by TDO2-Augmented Fibroblasts Regulate Pro-inflammatory Response in Macrophages
por: Peck, Kiel A., et al.
Publicado: (2021)

Research progress of gut microbiota in hepatocellular carcinoma
por: Li, Keliu, et al.
Publicado: (2022)

Analysis and Accuracy Improvement of UWB-TDoA-Based Indoor Positioning System
por: Grasso, Paolo, et al.
Publicado: (2022)

Id4 promotes cell proliferation in hepatocellular carcinoma
por: Zhang, Yang, et al.
Publicado: (2017)

Sleep Deprivation Disturbs Immune Surveillance and Promotes the Progression of Hepatocellular Carcinoma
por: Huang, Jing, et al.
Publicado: (2021)

Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner
por: Li, Fan, et al.
Publicado: (2021)

lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma
por: Li, Xiao, et al.
Publicado: (2018)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial–mesenchymal transition and promotes metastasis of colorectal cancer
por: Xiao, Chao, et al.
Publicado: (2019)

B-Cell Receptor-Associated Protein 31 Promotes Metastasis via AKT/β-Catenin/Snail Pathway in Hepatocellular Carcinoma
por: Liu, Tengfei, et al.
Publicado: (2021)

RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma
por: Su, Yang, et al.
Publicado: (2023)

RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells
por: Xie, Changji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ld2h55kih08fe2uepsc3kadvc